You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Study finds primary-care doctors often overlook prostate cancer risk in Black men
- 2. Development and validation of a prostate cancer risk prediction model for the elevated PSA population
- 3. The predictive value of PSMA PET/CT in determining pathological upgrading of prostate cancer: A pooling up analysis
- 4. New hurdle seen to prostate screening: primary-care docs
- 5. SEPTEMBER IS PROSTATE CANCER AWARENESS MONTH: PROCURE PROTON THERAPY CENTER ENCOURAGES MEN TO LEARN ABOUT THEIR OPTIONS
- 6. Orthocell's Remplir used in nerve-sparing prostate cancer surgery
- 7. Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
- 8. Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
- 9. The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
- 10. ‘I was told I had two weeks to live' – why are so many young, fit, non-smoking women getting lung cancer?
Last updated at 19:56 GMT
Hot News Makers
Health/Pharma Companies
-
346489.43
-
270761.04
-
35430.99
-
24958.48
-
14682.31
-
14451.35
-
12655.51
-
11053.94
-
10439.21
-
9818.20
Drugs, Treatments, Trials
-
20276.77
-
7774.84
-
7408.22
-
4132.33
-
3246.75
-
3085.90
-
2682.09
-
2570.34
-
2326.13
-
2128.85
Last updated at 19:10 GMT
